XML 37 R2.htm IDEA: XBRL DOCUMENT v3.23.1
Pay vs Performance Disclosure - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Pay vs Performance Disclosure [Table]      
Pay vs Performance [Table Text Block]
PAY VERSUS PERFORMANCE
As required by Section 953(a) of the Dodd-Frank Wall Street Reform and Consumer Protection A
ct and
Item 402(v) of Regulation
S-K,
the Company is providing information about the relationship between executive compensation actually paid to Mr. Hunt, who is the Principal Executive Officer (“PEO”), and the other NEOs (as calculated in accordance with 402(v) of Regulation
S-K)
and certain financial performance measures. For additional information on the Company’s compensation programs and philosophy and how the Company designs its compensation programs to align pay with performance, see the section titled
“Compensation Discussion and Analysis – Compensation Objectives”
on page 38.
Pay Versus Performance Table
 
                                                             
                         
Value of Initial Fixed $100
Investment Based On:
              
Year
  
Summary
Compensation
on Table Total
for PEO
($)
 
  
Compensation
Actually Paid
to PEO
($) 
(1)
 
    
Average
Summary
Compensation
Table Total
for
Non-PEO

NEOs
($)
 
    
Average
Compensation
Actually Paid
to
Non-PEO

NEOs
($) 
(2)
 
    
Total
Shareholder
Return
($) 
(3)
 
    
Peer Group
Total
Shareholder
Return
($) 
(4)
 
    
Net Income
($) 
(5)
 
    
Adjusted
Revenue
($) 
(6)
 
  
                 
2022
  
   7,713,930
  
 
(14,037,928
) 
  
 
2,030,204
  (7)
 
  
 
373,690
  (7)
 
  
 
183     
 
  
 
111     
 
  
 
185,958,784
 
  
 
823,421,806
 
                 
2021
  
   7,765,070
  
 
28,761,887
 
  
 
1,903,210
  (7)
 
  
 
3,095,727
  (7)
 
  
 
286     
 
  
 
125     
 
  
 
128,290,831
 
  
 
666,832,455
 
                 
2020
  
   5,066,061
  
 
36,587,864
 
  
 
1,660,855
  (8)
 
  
 
4,883,849
  (8)
 
  
 
207     
 
  
 
126     
 
  
 
59,925,688
 
  
 
360,009,590
 
 
 
(1)
The amounts reported represent the “compensation actually paid” to Mr. Hunt, computed in accordance with Item 402(v) of Regulation
S-K,
but do not reflect the actual amount of compensation earned by or paid to Mr. Hunt in the applicable year. In accordance with Item 402(v) of Regulation
S-K,
the following adjustments were made to the amount reported for Mr. Hunt in the “Total” column of the Summary Compensation Table for each year to calculate compensation actually paid:
 
                                 
Year
  
Summary Compensation
Table Total for PEO
($)
 
    
Summary Compensation
Table Value of Equity
Awards
($) 
(a)
 
    
Equity Award
Adjustments
($) 
(b)
 
    
Compensation Actually
Paid to PEO
($)
 
  
         
2022
  
 
7,713,930
 
  
 
(6,123,490
) 
  
 
(15,628,368
) 
  
 
(14,037,928
) 
         
2021
  
 
7,765,070
 
  
 
(5,663,515
) 
  
 
26,660,332
 
  
 
28,761,887
 
         
2020
  
 
5,066,061
 
  
 
(3,957,311
) 
  
 
35,479,114
 
  
 
36,587,864
 
 
 
(a)
The amounts reported represent the sum of the amounts reported in the “Stock Awards” and “Option Awards” columns of the Summary Compensation Table for the applicable year.
 
 
(b)
The amounts deducted or added in calculating the equity award adjustments are as follows and the valuation assumptions used to calculate fair values did not materially differ from those disclosed at the time of the grant:
 
                                                         
Year
  
Year End Fair
Value of
Equity
Awards
($)
 
    
Year Over
Year Change
in Fair Value of
Outstanding
and Unvested
Equity Awards
($)
 
    
Fair Value as of
Vesting Date
of Equity
Awards
Granted and
Vested in the
Year
($)
 
    
Year Over Year
Change in Fair
Value of
Equity Awards
Granted in
Prior Years
that Vested in
the Year
($)
 
    
Fair Value at the
End of the Prior
Year of Equity
Awards that
Failed to Meet
Vesting
Conditions in
the Year
($)
 
    
Value of
Dividends or
other Earnings
Paid on Stock or
Option Awards
not Otherwise
Reflected in Fair
Value or Total
Compensation
($)
 
    
Total Equity
Award
Adjustments
($)
 
  
               
2022
  
 
5,089,051
 
  
 
(16,700,137
) 
  
 
—
 
  
 
(4,017,282
) 
  
 
—
 
  
 
—
 
  
 
(15,628,368
) 
               
2021
  
 
5,871,874
 
  
 
18,454,854
 
  
 
—
 
  
 
2,333,604
 
  
 
—
 
  
 
—
 
  
 
26,660,332
 
               
2020
  
 
8,611,644
 
  
 
27,291,322
 
  
 
—
 
  
 
(423,852
) 
  
 
—
 
  
 
—
 
  
 
35,479,114
 
 
 
(2)
The amounts reported represent the average “compensation actually paid” to the NEOs other than Mr. Hunt as a group, computed in accordance with Item 402(v) of Regulation
S-K.
The amounts do not reflect the actual average amount of compensation earned by or paid to such NEOs as a group in the applicable year. In accordance with Item 402(v) of Regulation
S-K,
the following adjustments were made to the average of the amounts reported in the “Total” column of the Summary Compensation Table for the NEOs as a group (excluding Mr. Hunt) for each year to determine the compensation actually paid, using the same methodology described above in footnote 1:
 
 
                                 
Year
  
Average Reported Summary
Compensation Table Total
for
Non-PEO
NEOs
($)
 
    
Average Summary
Compensation Table Value
of Equity Awards
($) 
(a)
 
    
Average Equity Award
Adjustments
($) 
(b)
 
    
Average Compensation
Actually Paid to
Non-PEO
NEOs
($)
 
  
         
2022
  
 
2,030,204
 
  
 
(1,293,539
) 
  
 
(362,975
) 
  
 
373,690
 
         
2021
  
 
1,903,210
 
  
 
(1,158,499
) 
  
 
2,351,016
 
  
 
3,095,727
 
         
2020
  
 
1,660,855
 
  
 
(991,336
) 
  
 
4,214,330
 
  
 
4,883,849
 
 
 
(a)
The amounts reported represent the average of the sum of the amounts reported in the “Stock Awards” and “Option Awards” columns in the Summary Compensation Table for the applicable fiscal year.
 
 
(b)
The amounts deducted or added in calculating for equity award adjustments are as follows:
 
                                                         
Year
  
Year End Fair
Value of
Equity
Awards
($)
 
    
Year Over
Year Change
in Fair Value
of
Outstanding
and
Unvested
Equity
Awards
($)
 
    
Fair Value as of
Vesting Date
of Equity
Awards
Granted and
Vested in the
Year
($)
 
    
Year Over Year
Change in Fair
Value of
Equity Awards
Granted in
Prior Years
that Vested in
the Year
($)
 
    
Fair Value at the
End of the Prior
Year of Equity
Awards that
Failed to Meet
Vesting
Conditions in
the Year
($)
 
    
Value of
Dividends or
other Earnings
Paid on Stock or
Option Awards
not Otherwise
Reflected in Fair
Value or Total
Compensation
($)
 
    
Total Equity
Award
Adjustments
($)
 
  
               
2022
  
 
972,047
 
  
 
(895,955
) 
  
 
—
 
  
 
(426,369
) 
  
 
(12,698
) 
  
 
—
 
  
 
(362,975
) 
               
2021
  
 
1,240,869
 
  
 
923,948
 
  
 
—
 
  
 
186,199
 
  
 
—
 
  
 
—
 
  
 
2,351,016
 
               
2020
  
 
2,164,711
 
  
 
1,959,514
 
  
 
—
 
  
 
90,105
 
  
 
—
 
  
 
—
 
  
 
4,214,330
 
 
 
(3)
Total shareholder return (“TSR”) is calculated by dividing the sum of the cumulative amount of dividends for the measurement period, assuming dividend reinvestment, and the difference between the Company’s share price at the end and the beginning of the measurement period by the Company’s share price at the beginning of the measurement period.
 
 
(4)
Represents the weighted peer group TSR. The peer group used for this purpose is the Nasdaq Biotechnology Index, a published industry index.
 
 
(5)
The dollar amounts reported represent the amount of net income reflected in the Company’s audited financial statements for the applicable fiscal year.
 
 
(6)
Adjusted revenue is defined as the Company’s total consolidated revenue as reported under U.S. GAAP adjusted to reflect the impact of acquisitions. In 2022, there was a $21.9 million favorable impact on total
as-reported
consolidated revenue of $801.5 million related to the change in foreign exchange rates. In 2021, the total
as-reported
consolidated revenue of $670.5 million was adjusted (decreased) by $3.7 million, resulting in adjusted revenue of $666.8 million. In 2020, the
as-reported
consolidated revenue of $366.3 million was adjusted (decreased) by $6.3 million, resulting in adjusted revenue of $360.0 million. While the Company considers numerous financial and
non-financial
performance measures for the purpose of evaluating and determining executive compensation, the Company considers adjusted revenue, which is one of the Corporate Objectives (along with adjusted EPS) used to determine annual cash incentive compensation paid to the NEOs for fiscal year 2022, to be the most important financial performance measure used to link compensation actually paid to Company performance for fiscal year 2022.
 
 
(7)
Non-PEO
NEOs for 2021 and 2022 include Mr. Snodgres, Mr. Bylund, Ms. Gebski and Mr. Kuriyel.
 
 
(8)
Non-PEO
NEOs for 2020 include Mr. Snodgres and Mr. Kuriyel.
   
Company Selected Measure Name Adjusted revenue    
Named Executive Officers, Footnote [Text Block]
Non-PEO
NEOs for 2021 and 2022 include Mr. Snodgres, Mr. Bylund, Ms. Gebski and Mr. Kuriyel.
Non-PEO
NEOs for 2021 and 2022 include Mr. Snodgres, Mr. Bylund, Ms. Gebski and Mr. Kuriyel.
Non-PEO
NEOs for 2020 include Mr. Snodgres and Mr. Kuriyel.
Peer Group Issuers, Footnote [Text Block] Represents the weighted peer group TSR. The peer group used for this purpose is the Nasdaq Biotechnology Index, a published industry index.    
PEO Total Compensation Amount $ 7,713,930 $ 7,765,070 $ 5,066,061
PEO Actually Paid Compensation Amount $ (14,037,928) 28,761,887 36,587,864
Adjustment To PEO Compensation, Footnote [Text Block]
 
(1)
The amounts reported represent the “compensation actually paid” to Mr. Hunt, computed in accordance with Item 402(v) of Regulation
S-K,
but do not reflect the actual amount of compensation earned by or paid to Mr. Hunt in the applicable year. In accordance with Item 402(v) of Regulation
S-K,
the following adjustments were made to the amount reported for Mr. Hunt in the “Total” column of the Summary Compensation Table for each year to calculate compensation actually paid:
 
                                 
Year
  
Summary Compensation
Table Total for PEO
($)
 
    
Summary Compensation
Table Value of Equity
Awards
($) 
(a)
 
    
Equity Award
Adjustments
($) 
(b)
 
    
Compensation Actually
Paid to PEO
($)
 
  
         
2022
  
 
7,713,930
 
  
 
(6,123,490
) 
  
 
(15,628,368
) 
  
 
(14,037,928
) 
         
2021
  
 
7,765,070
 
  
 
(5,663,515
) 
  
 
26,660,332
 
  
 
28,761,887
 
         
2020
  
 
5,066,061
 
  
 
(3,957,311
) 
  
 
35,479,114
 
  
 
36,587,864
 
 
 
(a)
The amounts reported represent the sum of the amounts reported in the “Stock Awards” and “Option Awards” columns of the Summary Compensation Table for the applicable year.
 
 
(b)
The amounts deducted or added in calculating the equity award adjustments are as follows and the valuation assumptions used to calculate fair values did not materially differ from those disclosed at the time of the grant:
 
                                                         
Year
  
Year End Fair
Value of
Equity
Awards
($)
 
    
Year Over
Year Change
in Fair Value of
Outstanding
and Unvested
Equity Awards
($)
 
    
Fair Value as of
Vesting Date
of Equity
Awards
Granted and
Vested in the
Year
($)
 
    
Year Over Year
Change in Fair
Value of
Equity Awards
Granted in
Prior Years
that Vested in
the Year
($)
 
    
Fair Value at the
End of the Prior
Year of Equity
Awards that
Failed to Meet
Vesting
Conditions in
the Year
($)
 
    
Value of
Dividends or
other Earnings
Paid on Stock or
Option Awards
not Otherwise
Reflected in Fair
Value or Total
Compensation
($)
 
    
Total Equity
Award
Adjustments
($)
 
  
               
2022
  
 
5,089,051
 
  
 
(16,700,137
) 
  
 
—
 
  
 
(4,017,282
) 
  
 
—
 
  
 
—
 
  
 
(15,628,368
) 
               
2021
  
 
5,871,874
 
  
 
18,454,854
 
  
 
—
 
  
 
2,333,604
 
  
 
—
 
  
 
—
 
  
 
26,660,332
 
               
2020
  
 
8,611,644
 
  
 
27,291,322
 
  
 
—
 
  
 
(423,852
) 
  
 
—
 
  
 
—
 
  
 
35,479,114
 
    
Non-PEO NEO Average Total Compensation Amount $ 2,030,204 1,903,210 1,660,855
Non-PEO NEO Average Compensation Actually Paid Amount $ 373,690 3,095,727 4,883,849
Adjustment to Non-PEO NEO Compensation Footnote [Text Block]
 
(2)
The amounts reported represent the average “compensation actually paid” to the NEOs other than Mr. Hunt as a group, computed in accordance with Item 402(v) of Regulation
S-K.
The amounts do not reflect the actual average amount of compensation earned by or paid to such NEOs as a group in the applicable year. In accordance with Item 402(v) of Regulation
S-K,
the following adjustments were made to the average of the amounts reported in the “Total” column of the Summary Compensation Table for the NEOs as a group (excluding Mr. Hunt) for each year to determine the compensation actually paid, using the same methodology described above in footnote 1:
 
 
                                 
Year
  
Average Reported Summary
Compensation Table Total
for
Non-PEO
NEOs
($)
 
    
Average Summary
Compensation Table Value
of Equity Awards
($) 
(a)
 
    
Average Equity Award
Adjustments
($) 
(b)
 
    
Average Compensation
Actually Paid to
Non-PEO
NEOs
($)
 
  
         
2022
  
 
2,030,204
 
  
 
(1,293,539
) 
  
 
(362,975
) 
  
 
373,690
 
         
2021
  
 
1,903,210
 
  
 
(1,158,499
) 
  
 
2,351,016
 
  
 
3,095,727
 
         
2020
  
 
1,660,855
 
  
 
(991,336
) 
  
 
4,214,330
 
  
 
4,883,849
 
 
 
(a)
The amounts reported represent the average of the sum of the amounts reported in the “Stock Awards” and “Option Awards” columns in the Summary Compensation Table for the applicable fiscal year.
 
 
(b)
The amounts deducted or added in calculating for equity award adjustments are as follows:
 
                                                         
Year
  
Year End Fair
Value of
Equity
Awards
($)
 
    
Year Over
Year Change
in Fair Value
of
Outstanding
and
Unvested
Equity
Awards
($)
 
    
Fair Value as of
Vesting Date
of Equity
Awards
Granted and
Vested in the
Year
($)
 
    
Year Over Year
Change in Fair
Value of
Equity Awards
Granted in
Prior Years
that Vested in
the Year
($)
 
    
Fair Value at the
End of the Prior
Year of Equity
Awards that
Failed to Meet
Vesting
Conditions in
the Year
($)
 
    
Value of
Dividends or
other Earnings
Paid on Stock or
Option Awards
not Otherwise
Reflected in Fair
Value or Total
Compensation
($)
 
    
Total Equity
Award
Adjustments
($)
 
  
               
2022
  
 
972,047
 
  
 
(895,955
) 
  
 
—
 
  
 
(426,369
) 
  
 
(12,698
) 
  
 
—
 
  
 
(362,975
) 
               
2021
  
 
1,240,869
 
  
 
923,948
 
  
 
—
 
  
 
186,199
 
  
 
—
 
  
 
—
 
  
 
2,351,016
 
               
2020
  
 
2,164,711
 
  
 
1,959,514
 
  
 
—
 
  
 
90,105
 
  
 
—
 
  
 
—
 
  
 
4,214,330
 
    
Compensation Actually Paid vs. Total Shareholder Return [Text Block]
Compensation Actually Paid and Company TSR
The graph below describes the relationship between compensation actually paid to Mr. Hunt and the average compensation actually paid to the Company’s other NEOs to the Company’s TSR over the three-year period from December 31, 2019 to December 31, 2022, assuming an initial investment of $100 on December 31, 2019. As the graph shows, this relationship is generally aligned in large part because a significant portion of the compensation actually paid to the Company’s NEOs is in the form of equity awards, the value of which is impacted by the stock price changes.
 
LOGO
 
    
Compensation Actually Paid vs. Net Income [Text Block]
Compensation Actually Paid and Net Income
The graph below shows the relationship between compensation actually paid to Mr. Hunt and the average compensation actually paid to the Company’s other NEOs to the Company’s net income for the three years presented in the Pay Versus Performance Table. The Company does not use net income as a performance measure in its executive compensation program:
 
LOGO
   
Compensation Actually Paid vs. Company Selected Measure [Text Block]
Compensation Actually Paid and Adjusted Revenue
The graph below shows the relationship between compensation actually paid to Mr. Hunt and the
average
compensation actually paid to the Company’s other NEOs to the Company’s adjusted revenue for the three years presented in the Pay Versus Performance Table. As described above, adjusted revenue is defined as the Company’s total consolidated revenue as reported under U.S. GAAP, adjusted to reflect the impact of acquisitions. While the Company uses numerous financial and
non-financial
performance measures in its compensation programs, the Company has determined that adjusted revenue is the most important performance measure used to link compensation actually paid to the Company’s NEOs for fiscal year 2022 to Company performance. The Company uses adjusted revenue (along with adjusted EPS, both of which are weighted equally) as one of the Corporate Objectives in the Company’s short-term incentive compensation program:
 
LOGO
 
    
Total Shareholder Return Vs Peer Group [Text Block]
Total Shareholder Return
The graph below describes the relationship between Repligen Corporation’s (Nasdaq:RGEN) TSR and the TSR for the Nasdaq Biotechnology index:
 
LOGO
   
Tabular List [Table Text Block]
Tabular List of Performance Measures
The following table includes financial performance measures that the Company has determined are its
most
important financial performance measures for 2022 and how they were used in relation to executive compensation:
 
     
Financial Measure
  
Application in Most Recently
Completed Fiscal Year’s Compensation
 
   
Adjusted revenue
  
Annual Cash Incentive Compensation – Corporate Objectives
   
Adjusted EPS
  
Annual Cash Incentive Compensation – Corporate Objectives
   
Adjusted ROIC
  
Long-term Incentive Plan – PSU Portion
(3-year
goal)
   
Base Organic Growth
  
Long-term Incentive Plan – PSU Portion
(3-year
goal)
    
Total Shareholder Return Amount $ 183 286 207
Peer Group Total Shareholder Return Amount 111 125 126
Net Income (Loss) $ 185,958,784 $ 128,290,831 $ 59,925,688
Company Selected Measure Amount 823,421,806 666,832,455 360,009,590
PEO Name Mr. Hunt Mr. Hunt Mr. Hunt
Additional 402(v) Disclosure [Text Block]
Description of Relationship Between Compensation Actually Paid and Selected Performance Metrics
As described above in the section titled
“Compensation and Discussion Analysis – Compensation Objectives”
on page 38, the Company’s compensation program is designed to attract and retain high-performing talent in the bioprocessing industry, motivate the Company’s executive officers to create long-term, enhanced shareholder value, and provide a fair reward for executive effort and stimulate professional and personal growth. The Company uses several performance measures to align executive compensation with Company performance, not all of which are presented in the Pay Versus Performance Table above. Moreover, the Company calculates compensation to the PEO and other NEOs on a basis different than the amount reported in the Summary Compensation Table and compensation actually paid, as calculated in accordance with Item 402(v) of Regulation
S-K,
is not considered by the Board and the Compensation Committee in evaluating or determining executive compensation. In addition, the Board and the Compensation Committee do not use TSR or net income as performance measures when making pay compensation decisions. In accordance with Item 402(v) of Regulation
S-K,
the Company is providing the following descriptions of the relationships between compensation actually paid and the financial performance metrics presented in the Pay Versus Performance Table. 		   
Total Company Selected Measure Amount   670,500,000 366,300,000
Company Selected Measure Amount Adjusted (Decreased)   3,700,000 6,300,000
Impact on Consolidated Revenue 21,900,000    
Total Company Selected Measure Amount Related to Change in Foreign Exchange Rate 801,500,000    
Measure [Axis]: 1      
Pay vs Performance Disclosure [Table]      
Measure Name Adjusted revenue    
Measure [Axis]: 2      
Pay vs Performance Disclosure [Table]      
Measure Name Adjusted EPS    
Measure [Axis]: 3      
Pay vs Performance Disclosure [Table]      
Measure Name Adjusted ROIC    
Measure [Axis]: 4      
Pay vs Performance Disclosure [Table]      
Measure Name Base Organic Growth    
PEO [Member] | Value of Equity Awards [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount $ (6,123,490) $ (5,663,515) $ (3,957,311)
PEO [Member] | Equity Award Adjustments [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount (15,628,368) 26,660,332 35,479,114
Fair Value of Equity Awards 5,089,051 5,871,874 8,611,644
Change in Fair Value of Outstanding and Unvested Equity Awards (16,700,137) 18,454,854 27,291,322
Fair Value Equity Awards Granted and Vested 0 0 0
Change in Fair Value of Equity Awards Granted, Vested (4,017,282) 2,333,604 (423,852)
Fair Value of Equity Awards that Failed to Meet Vesting Conditions 0 0 0
Value of Dividends or Other Earnings Paid on Stock or Option Awards 0 0 0
Non-PEO NEO [Member] | Value of Equity Awards [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount (1,293,539) (1,158,499) (991,336)
Non-PEO NEO [Member] | Equity Award Adjustments [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount (362,975) 2,351,016 4,214,330
Fair Value of Equity Awards 972,047 1,240,869 2,164,711
Change in Fair Value of Outstanding and Unvested Equity Awards (895,955) 923,948 1,959,514
Fair Value Equity Awards Granted and Vested 0 0 0
Change in Fair Value of Equity Awards Granted, Vested (426,369) 186,199 90,105
Fair Value of Equity Awards that Failed to Meet Vesting Conditions (12,698) 0 0
Value of Dividends or Other Earnings Paid on Stock or Option Awards $ 0 $ 0 $ 0